Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Soy isoflavones for breast cancer risk reduction.

Wu AH, Spicer DV, Pike MC.

Cancer Prev Res (Phila). 2012 Jul;5(7):984-5; author reply 986-7. doi: 10.1158/1940-6207.CAPR-12-0102. Epub 2012 Jun 12. No abstract available.

2.

Resolving the soy-breast cancer controversy.

Messina M.

J Am Diet Assoc. 2006 Mar;106(3):363-4. No abstract available.

PMID:
16503223
3.

Early life and adult exposure to isoflavones and breast cancer risk.

Tomar RS, Shiao R.

J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2008 Apr-Jun;26(2):113-73. doi: 10.1080/10590500802074256. Review.

PMID:
18569328
4.

Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.

Khan SA, Chatterton RT, Michel N, Bryk M, Lee O, Ivancic D, Heinz R, Zalles CM, Helenowski IB, Jovanovic BD, Franke AA, Bosland MC, Wang J, Hansen NM, Bethke KP, Dew A, Coomes M, Bergan RC.

Cancer Prev Res (Phila). 2012 Feb;5(2):309-19. doi: 10.1158/1940-6207.CAPR-11-0251.

5.

Soy for breast cancer survivors: a critical review of the literature.

Messina MJ, Loprinzi CL.

J Nutr. 2001 Nov;131(11 Suppl):3095S-108S. Review.

6.

Early intake appears to be the key to the proposed protective effects of soy intake against breast cancer.

Messina M, Hilakivi-Clarke L.

Nutr Cancer. 2009;61(6):792-8. doi: 10.1080/01635580903285015.

PMID:
20155618
7.

Legumes and soybeans: overview of their nutritional profiles and health effects.

Messina MJ.

Am J Clin Nutr. 1999 Sep;70(3 Suppl):439S-450S. Review.

8.

Disposition of soy isoflavones in normal human breast tissue.

Bolca S, Urpi-Sarda M, Blondeel P, Roche N, Vanhaecke L, Possemiers S, Al-Maharik N, Botting N, De Keukeleire D, Bracke M, Heyerick A, Manach C, Depypere H.

Am J Clin Nutr. 2010 Apr;91(4):976-84. doi: 10.3945/ajcn.2009.28854. Epub 2010 Feb 17.

9.

Re: Soy, isoflavones, and breast cancer risk in Japan.

Fujimaki S, Hayashi K.

J Natl Cancer Inst. 2003 Dec 17;95(24):1881-2; author reply 1881-2. No abstract available.

PMID:
14679159
10.

Differential influence of dietary soy intake on the risk of breast cancer recurrence related to HER2 status.

Woo HD, Park KS, Ro J, Kim J.

Nutr Cancer. 2012;64(2):198-205. doi: 10.1080/01635581.2012.635261. Epub 2012 Jan 2.

PMID:
22211813
11.

Eating to beat breast cancer: potential role for soy supplements.

Stoll BA.

Ann Oncol. 1997 Mar;8(3):223-5.

PMID:
9137789
12.

Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County.

Wu AH, Yu MC, Tseng CC, Twaddle NC, Doerge DR.

Carcinogenesis. 2004 Jan;25(1):77-81. Epub 2003 Oct 10.

PMID:
14555615
13.

Dietary soy intake and breast cancer risk.

Enderlin CA, Coleman EA, Stewart CB, Hakkak R.

Oncol Nurs Forum. 2009 Sep;36(5):531-9. doi: 10.1188/09.ONF.531-539.

PMID:
19726393
14.
15.

Intake of phytoestrogen foods and supplements among women recently diagnosed with breast cancer in Ontario, Canada.

Boucher BA, Cotterchio M, Curca IA, Kreiger N, Harris SA, Kirsh VA, Goodwin PJ.

Nutr Cancer. 2012;64(5):695-703. doi: 10.1080/01635581.2012.687426. Epub 2012 May 29.

PMID:
22642930
17.

Enhanced estrogenic responses and sensitivity to azoxymethane following dietary soy isoflavone supplementation in older female rats.

Daly KT, Tracy AC, Malik M, Wang T, Francke-Carroll S, Magnuson BA.

Food Chem Toxicol. 2007 Apr;45(4):628-37. Epub 2006 Nov 2.

PMID:
17157426
18.

Soy isoflavones increase latency of spontaneous mammary tumors in mice.

Jin Z, MacDonald RS.

J Nutr. 2002 Oct;132(10):3186-90.

19.

[Effect of soy isoflavones on the incidence of 7, 12-dimethylbenz (alpha) anthracene-induced breast tumors in rats].

Hu JW, Zhao XH, Zhang YM, Wang PY.

Beijing Da Xue Xue Bao. 2010 Jun 18;42(3):288-92. Chinese.

20.

Perspectives on the soy-breast cancer relation.

Messina M, Wu AH.

Am J Clin Nutr. 2009 May;89(5):1673S-1679S. doi: 10.3945/ajcn.2009.26736V. Epub 2009 Apr 1.

Supplemental Content

Support Center